Current Health, whose tech helps healthcare organizations provide and manage patient care remotely, raises $43M Series B following a 3,000% YoY rise in revenue
At-home healthcare was a growing trend before the COVID-19 pandemic, but the current health crisis has only accelerated the shift …
Context & Ripple Effects
This round closes the loop on Current Health's own arc: the company raised an $11.5M Series A led by MMC Ventures in late 2019 for its AI-powered remote patient management platform, and the new $43M Series B arrives alongside a reported 3,000% year-over-year revenue increase — growth the company attributes to the pandemic pulling at-home care into the mainstream.
The raise fits a crowded funding lane. Medici pulled in a $24M Series B at the pandemic's onset, Ready raised a $54M Series C for on-demand home medical care, and Meru Health later cited ~700% revenue growth in its own Series B — making Current Health's 3,000% figure the steepest claimed trajectory among its direct peers.
First-order effects
- Current Health now has roughly four times its prior total capital to scale deployments for healthcare organizations managing patients remotely, converting pandemic-era demand spikes into contracted platform relationships.
- MMC Ventures and the Series A syndicate hold a marked-up position just 16 months after leading the earlier round, with the revenue multiple doing the valuation work rather than projections.
Second-order effects
- Rivals defining 'home care' differently — Medici's telemedicine visits, Ready's on-demand clinician dispatch — now compete against a well-funded player selling continuous AI-based monitoring, forcing each to clarify whether they are a visit service or a data platform.
- Healthcare organizations evaluating remote-care vendors gain leverage from a funded, comparable field: pricing and integration terms across the category tighten as buyers can credibly run bake-offs between Current Health, Medici, and Ready.
Third-order effects
- If the funding cadence holds, home-based care consolidates around a monitoring-and-data layer sitting above episodic virtual visits — the connected-device, data-driven telehealth model sketched in early-pandemic coverage becoming the category's default architecture.
- The adjacent signal from Cynerio's healthcare-IoT security raise suggests the structural follow-on: as patient monitoring moves into homes, device security and data governance become procurement requirements rather than afterthoughts.
The trend: Venture capital is consolidating behind remote patient management as the durable post-pandemic form of healthcare delivery, with monitoring platforms out-raising visit-based telemedicine.